Effect of Ankyrin-1 polyphenol on vascular alterations in type 2 diabetes mellitus in rats
Journal of Advanced Biotechnology and Experimental Therapeutics · 2026 · 9 (2) · 180
DOI: 10.5455/jabet.2026.14 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Advanced Biotechnology and Experimental Therapeutics, 2026. Verfasst von Guli Raimova und 11 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes mellitus (T2DM) is strongly associated with endothelial dysfunction, altered vascular reactivity, and a prothrombotic shift in hemostasis, which together increase the risk of cardiovascular complications. Plant polyphenols have attracted attention as multifunctional bioactive molecules with antioxidant and anti-inflammatory properties. This study evaluated the corrective effect of the polyphenol ANK-1 (isolated from Pistacia vera L.) on vascular dysfunction and hemostatic/platelet alterations in rats with experimentally induced T2DM, with metformin used as a reference drug. T2DM was induced in outbred male albino rats by 60-day high-fat feeding followed by a single intraperitoneal injection of streptozotocin (35 mg/kg; 0.1 M citrate buffer, pH 4.5). Biochemical indices (glucose, ALT, AST, total cholesterol, triglycerides, insulin, HOMA-IR), coagulation tests (PT, APTT, plasma recalcification time, fibrinogen), and platelet aggregation (ADP, collagen, epinephrine) were assessed. Vascular reactivity of isolated aortic rings was examined using KCl- and phenylephrine-induced contractions and concentration-dependent vasorelaxation, including endothelium-denuded conditions and pharmacological inhibition (L-NAME, methylene blue, indomethacin). The T2DM model produced hyperglycemia, dyslipidemia, increased transaminase activity, hypercoagulation, and enhanced platelet aggregation. Oral ANK-1 (10 mg/kg, 10 days) improved glycemic and lipid parameters, attenuated hypercoagulability, and reduced ADP-, collagen-, and epinephrine-induced platelet aggregation. In aortic rings, ANK-1 partially restored contractile responses and produced marked vasorelaxation that was reduced after endothelial removal and in the presence of L-NAME and methylene blue, indicating involvement of the NO/sGC/cGMP pathway. ANK-1 demonstrates vasoprotective and antithrombotic potential in experimental T2DM, likely mediated by endothelium-dependent mechanisms linked to NO signaling and modulation of Ca²⁺-dependent vascular and platelet activation.
Zitieren
APA
Raimova, G., Khoshimov, N., Nasirov, K., Khodjiev, S., Makhmudov, R., Fazilbekova, D., Mamatova, Z., Nodira, M., Akbarova, G., Tavaldieva, G., Toshtemirova, M., & Safarova, D. (2026). Effect of Ankyrin-1 polyphenol on vascular alterations in type 2 diabetes mellitus in rats. Journal of Advanced Biotechnology and Experimental Therapeutics, 9(2), 180. https://doi.org/10.5455/jabet.2026.14
Vancouver
Raimova G, Khoshimov N, Nasirov K, Khodjiev S, Makhmudov R, Fazilbekova D, et al. Effect of Ankyrin-1 polyphenol on vascular alterations in type 2 diabetes mellitus in rats. Journal of Advanced Biotechnology and Experimental Therapeutics. 2026;9(2):180. doi:10.5455/jabet.2026.14
BibTeX
@article{Raimova2026,
author = {Raimova, Guli and Khoshimov, Nozim and Nasirov, Kabil and Khodjiev, Siroj and Makhmudov, Rustam and Fazilbekova, Dilnaza and Mamatova, Zulaykho and Nodira, Mamadaliyeva and Akbarova, Gulbakhor and Tavaldieva, Gulbakhar and Toshtemirova, Muazzam and Safarova, Dilbar},
title = {Effect of Ankyrin-1 polyphenol on vascular alterations in type 2 diabetes mellitus in rats},
journal = {Journal of Advanced Biotechnology and Experimental Therapeutics},
year = {2026},
volume = {9},
number = {2},
pages = {180},
doi = {10.5455/jabet.2026.14}
}
EUVIMED